NEW YORK, Oct. 28 (GenomeWeb News) - Invitrogen yesterday reported a 13-percent year-over year increase in third-quarter revenues, of which 12 percent was attributed to acquisitions. The company posted a 15-percent decrease in net income, however, related to its recent purchase of Dynal Biotech.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.